Stefan Stender

6.1k total citations · 2 hit papers
47 papers, 2.5k citations indexed

About

Stefan Stender is a scholar working on Epidemiology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Stefan Stender has authored 47 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Epidemiology, 15 papers in Surgery and 13 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Stefan Stender's work include Liver Disease Diagnosis and Treatment (23 papers), Diet, Metabolism, and Disease (11 papers) and Genetic Associations and Epidemiology (9 papers). Stefan Stender is often cited by papers focused on Liver Disease Diagnosis and Treatment (23 papers), Diet, Metabolism, and Disease (11 papers) and Genetic Associations and Epidemiology (9 papers). Stefan Stender collaborates with scholars based in Denmark, United States and United Kingdom. Stefan Stender's co-authors include Anne Tybjærg‐Hansen, Børge G. Nordestgaard, Helen H. Hobbs, Jonathan C. Cohen, Julia Kozlitina, Ēriks Šmagris, Heather Zhou, Thomas Vogt, Ruth Frikke‐Schmidt and Helene Gellert‐Kristensen and has published in prestigious journals such as Journal of Clinical Investigation, Nature Genetics and Journal of the American College of Cardiology.

In The Last Decade

Stefan Stender

45 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease

2014 867 citations Julia Kozlitina, Stefan Stender et al. Nature Genetics profile →
Adiposity amplifies the genetic risk of fatty liver disease conferred by multiple loci

2017 285 citations Stefan Stender, Julia Kozlitina et al. Nature Genetics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stefan Stender Denmark	22	1.6k	919	560	506	443	47	2.5k
Vlad Ratziu France	27	2.6k 1.6×	890 1.0×	437 0.8×	1.6k 3.2×	883 2.0×	68	3.7k
Hays Arnold United States	9	1.3k 0.8×	478 0.5×	430 0.8×	770 1.5×	291 0.7×	14	1.8k
Yuya Seko Japan	28	2.8k 1.7×	872 0.9×	446 0.8×	1.9k 3.8×	438 1.0×	114	3.5k
Claudia O. Zein United States	17	1.7k 1.1×	746 0.8×	381 0.7×	1.0k 2.0×	170 0.4×	32	2.1k
Paolo De Paolis Italy	12	1.1k 0.7×	420 0.5×	455 0.8×	523 1.0×	190 0.4×	53	1.6k
George A. Bannayan United States	17	1.2k 0.8×	801 0.9×	401 0.7×	332 0.7×	499 1.1×	27	2.1k
Paul Angulo United States	8	1.6k 1.0×	817 0.9×	364 0.7×	757 1.5×	137 0.3×	8	1.9k
Franco Sasso Italy	11	1.4k 0.9×	676 0.7×	195 0.3×	608 1.2×	258 0.6×	20	2.1k
Jessica Dyson United Kingdom	23	1.8k 1.1×	308 0.3×	890 1.6×	1.7k 3.3×	205 0.5×	67	2.6k
Michiharu Komatsu Japan	27	1.4k 0.9×	254 0.3×	400 0.7×	970 1.9×	332 0.7×	66	1.9k

Countries citing papers authored by Stefan Stender

Since Specialization

Citations

This map shows the geographic impact of Stefan Stender's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Stender with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Stender more than expected).

Fields of papers citing papers by Stefan Stender

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Stender. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Stender. The network helps show where Stefan Stender may publish in the future.

Co-authorship network of co-authors of Stefan Stender

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Stender. A scholar is included among the top collaborators of Stefan Stender based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Stender. Stefan Stender is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Werge, Mikkel Parsberg, Nina Kimer, Anders Junker, et al.. (2024). Use of PNPLA3, TM6SF2, and HSD17B13 for detection of fibrosis in MASLD in the general population. Clinics and Research in Hepatology and Gastroenterology. 48(7). 102389–102389. 5 indexed citations

Nordestgaard, Børge G., et al.. (2024). Does SLC39A8 Ala391Thr Confer Risk of Chronic Liver Disease?. Antioxidants and Redox Signaling. 41(10-12). 591–596. 2 indexed citations

Christoffersen, Mette, Stefan Stender, & Anne Tybjærg‐Hansen. (2024). Polygenic risk scores for cardiovascular risk prediction: moving towards implementation into clinical practice?. European Heart Journal. 45(20). 1853–1855.

Christoffersen, Mette, et al.. (2024). Polygenic risk of high LDL cholesterol and ischemic heart disease in the general population. Atherosclerosis. 397. 118574–118574. 1 indexed citations

Stender, Stefan, George Davey Smith, & Tom G. Richardson. (2023). Genetic variation and elevated liver enzymes during childhood, adolescence and early adulthood. International Journal of Epidemiology. 52(5). 1341–1349. 2 indexed citations

Huang, Yun, Sara Stinson, Helene Bæk Juel, et al.. (2023). An adult‐based genetic risk score for liver fat associates with liver and plasma lipid traits in children and adolescents. Liver International. 43(8). 1772–1782. 3 indexed citations

Gellert‐Kristensen, Helene, Anne Tybjærg‐Hansen, Børge G. Nordestgaard, et al.. (2023). Genetic risk of fatty liver disease and mortality in the general population: A Mendelian randomization study. Liver International. 43(9). 1955–1965. 12 indexed citations

Fred, Rikard G., Julie Steen Pedersen, Jonatan J. Thompson, et al.. (2022). Single-cell transcriptome and cell type-specific molecular pathways of human non-alcoholic steatohepatitis. Scientific Reports. 12(1). 13484–13484. 25 indexed citations

Israelsen, Mads, Helene Bæk Juel, Sönke Detlefsen, et al.. (2020). Metabolic and Genetic Risk Factors Are the Strongest Predictors of Severity of Alcohol-Related Liver Fibrosis. Clinical Gastroenterology and Hepatology. 20(8). 1784–1794.e9. 57 indexed citations

10.

Nordestgaard, Ask Tybjærg, Stefan Stender, Børge G. Nordestgaard, & Anne Tybjærg‐Hansen. (2019). Coffee intake protects against symptomatic gallstone disease in the general population: a Mendelian randomization study. Journal of Internal Medicine. 287(1). 42–53. 11 indexed citations

11.

Stender, Stefan, Julia Kozlitina, Børge G. Nordestgaard, et al.. (2017). Adiposity amplifies the genetic risk of fatty liver disease conferred by multiple loci. Nature Genetics. 49(6). 842–847. 285 indexed citations breakdown →

12.

Stender, Stefan & Anne Tybjærg‐Hansen. (2016). Using human genetics to predict the effects and side-effects of drugs. Current Opinion in Lipidology. 27(2). 105–111. 8 indexed citations

13.

Stender, Stefan, et al.. (2015). Adult-onset liver disease and hepatocellular carcinoma in S-adenosylhomocysteine hydrolase deficiency. Molecular Genetics and Metabolism. 116(4). 269–274. 33 indexed citations

14.

Stender, Stefan, Ruth Frikke‐Schmidt, Børge G. Nordestgaard, & Anne Tybjærg‐Hansen. (2013). Extreme Bilirubin Levels as a Causal Risk Factor for Symptomatic Gallstone Disease. JAMA Internal Medicine. 173(13). 1222–1222. 38 indexed citations

15.

Smith, Andrew J., Philip Howard, Sonia Shah, et al.. (2012). Use of Allele-Specific FAIRE to Determine Functional Regulatory Polymorphism Using Large-Scale Genotyping Arrays. PLoS Genetics. 8(8). e1002908–e1002908. 21 indexed citations

16.

Benn, Marianne, Anne Tybjærg‐Hansen, Stefan Stender, Ruth Frikke‐Schmidt, & Børge G. Nordestgaard. (2011). Low-Density Lipoprotein Cholesterol and the Risk of Cancer: A Mendelian Randomization Study. JNCI Journal of the National Cancer Institute. 103(6). 508–519. 128 indexed citations

17.

Stender, Stefan, Ruth Frikke‐Schmidt, Børge G. Nordestgaard, & Anne Tybjærg‐Hansen. (2010). Sterol transporter adenosine triphosphate-binding cassette transporter G8, gallstones, and biliary cancer in 62,000 individuals from the general population. Hepatology. 53(2). 640–648. 42 indexed citations

18.

Stender, Stefan, Mary Murphy, Timothy O’Brien, et al.. (2007). Adeno-associated viral vector transduction of human mesenchymal stem cells. European Cells and Materials. 13. 93–99. 76 indexed citations

19.

Stender, Stefan, J. Dyerberg, Ole Færgeman, et al.. (1996). [Significance of food for patients with ischemic heart disease].. PubMed. 158(48). 6885–91. 1 indexed citations

20.

Skovby, Flemming, J. Dyerberg, Ole Færgeman, et al.. (1993). [Hyperlipidemia in children].. PubMed. 155(11). 810–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact